Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3, 4-methylenedioxymethamphetamine (MDMA)

Abstract

Abstract Systemic administration of 3, 4-methylenedioxymethamphetamine (MDMA) produces depletions of serotonin (5-HT) and its primary metabolite, 5-hydroxyindoleacetic acid (5-HIAA), decreases 5-HT reuptake sites and diminishes tryptophan hydroxylase …